A detailed history of R Squared LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, R Squared LTD holds 10,376 shares of ABBV stock, worth $2.06 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
10,376
Previous 1,110 834.77%
Holding current value
$2.06 Million
Previous $233 Million 728.15%
% of portfolio
1.06%
Previous 0.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$170.16 - $206.27 $1.58 Million - $1.91 Million
9,266 Added 834.77%
10,376 $1.93 Billion
Q1 2025

May 09, 2025

BUY
$169.2 - $216.66 $175,968 - $225,326
1,040 Added 1485.71%
1,110 $233 Million
Q4 2024

Jan 22, 2025

BUY
$164.99 - $203.87 $11,549 - $14,270
70 New
70 $12.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $351B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track R Squared LTD Portfolio

Follow R Squared LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R Squared LTD, based on Form 13F filings with the SEC.

News

Stay updated on R Squared LTD with notifications on news.